Xinran Li, Ph.D.

US Food and Drug Administration

Poster(s):

• (T1330-10-69) Evaluation of Applications for Topical Semisolid Drug Products with In Vitro Permeation Test and In Vivo Bioequivalence Study with Pharmacokinetic Endpoints
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET

• (T0930-12-80) Regulatory Challenges with Formulation Assessment of Parenteral Drug Products During ANDA Review: Case Studies and Considerations
  Tuesday, October 24, 2023

  9:30 AM – 10:30 AM ET